|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aptose Biosciences (NASDAQ: APTO) through any online brokerage.
There are no as such competitors for Aptose Biosciences.
The latest price target for Aptose Biosciences (NASDAQ: APTO) was reported by Oppenheimer on March 24, 2021. The analyst firm set a price target for 9.00 expecting APTO to rise to within 12 months (a possible 164.71% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aptose Biosciences (NASDAQ: APTO) is $3.4 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aptose Biosciences.
There is no upcoming split for Aptose Biosciences.
Aptose Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.